United States · FDA National Drug Code directory

Novartis Pharmaceuticals Corporation

Labeler · 175 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 0078-0937_09bbe9c5-f4a7-4140-8a74-809125cd7861

EGATEN

TABLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0659_27616611-6b9c-4e50-b93b-ed29c24f9857

ENTRESTO

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0696_27616611-6b9c-4e50-b93b-ed29c24f9857

ENTRESTO

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0777_27616611-6b9c-4e50-b93b-ed29c24f9857

ENTRESTO

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1231_27616611-6b9c-4e50-b93b-ed29c24f9857

ENTRESTO

PELLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1238_27616611-6b9c-4e50-b93b-ed29c24f9857

ENTRESTO

PELLET / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-9659_27616611-6b9c-4e50-b93b-ed29c24f9857

ENTRESTO

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-9777_27616611-6b9c-4e50-b93b-ed29c24f9857

ENTRESTO

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0501_9b5555ca-d9a2-4f50-8037-abbf702d0a27

Exelon

PATCH, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0502_9b5555ca-d9a2-4f50-8037-abbf702d0a27

Exelon

PATCH, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0503_9b5555ca-d9a2-4f50-8037-abbf702d0a27

Exelon

PATCH, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0488_7e675018-c404-4ea5-ac95-a18d7cb78301

Exforge

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0489_7e675018-c404-4ea5-ac95-a18d7cb78301

Exforge

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0490_7e675018-c404-4ea5-ac95-a18d7cb78301

Exforge

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0491_7e675018-c404-4ea5-ac95-a18d7cb78301

Exforge

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0559_e10fea42-c6e7-4584-9a0a-0709c5323cd8

Exforge HCT

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0560_e10fea42-c6e7-4584-9a0a-0709c5323cd8

Exforge HCT

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0561_e10fea42-c6e7-4584-9a0a-0709c5323cd8

Exforge HCT

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0562_e10fea42-c6e7-4584-9a0a-0709c5323cd8

Exforge HCT

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0563_e10fea42-c6e7-4584-9a0a-0709c5323cd8

Exforge HCT

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0468_17c39217-5502-420d-8d2e-799626756189

Exjade

TABLET, FOR SUSPENSION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0469_17c39217-5502-420d-8d2e-799626756189

Exjade

TABLET, FOR SUSPENSION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0470_17c39217-5502-420d-8d2e-799626756189

Exjade

TABLET, FOR SUSPENSION / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-1189_be81b091-bf01-4e82-b777-e90a0f697c37

FABHALTA

CAPSULE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0249_28456311-e797-457f-8a9e-54dca5a7a336

Femara

TABLET, FILM COATED / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0430_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0431_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0432_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0433_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

United States · Source reference 0078-0434_fd5dd3b3-6bdf-437e-a763-1a07f9631121

Focalin XR

CAPSULE, EXTENDED RELEASE / Novartis Pharmaceuticals Corporation

Browse companies in United States →